Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 2014

Nikki(Ethinyl Estradiol/Drospirenone)Lupin Limited logoLUPIN.NS

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Lupin Limited

$129K

Medicare cost, 2024

Medicare drug plans spent $129,423 on Nikki (ethinyl estradiol/drospirenone) in 2024, for 3,367 prescriptions and refills filled by 1,044 patients. Spending fell 25% from 2023 to 2024. Massachusetts accounts for the most spending ($8,562, 7% of the total). It is made by Lupin Limited (LUPIN.NS).

Medicare cost, 2024

$129K

-24.8% from 2023

Prescriptions

3,367

$38.44 per claim

Patients

1,044

1,143 prescribers

Total spending, 2024

$129K

$123.89 per patient

Questions and answers

How much does Medicare spend on Nikki?

Medicare prescription drug plans paid $129K for Nikki in 2024, for 3,367 prescriptions and refills to 1,044 patients (down 24.8% from 2023). The average cost per claim was $38.44.

Which state spends the most on Nikki?

Massachusetts had the highest Medicare cost for Nikki in 2024: $8,562 for 237 claims, followed by North Carolina ($8,537).

Who prescribes Nikki the most?

Carrie A Blissenbach, nurse practitioner in Warren, OH, had the highest Medicare cost for Nikki in 2024: 14 claims costing $761.

Who makes Nikki?

Nikki is made by Lupin Limited (LUPIN.NS), listed in the Medicare spending data as Lupin Pharmaceu.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Nikki was $129K in 2024, after a high of $210K in 2022.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Nikki, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Carrie A Blissenbach Warren, OHNurse Practitioner14Under 11$761
Layne T Barker Layton, UTInternal Medicine14Under 11$735
Jennifer B Rogers Winston Salem, NCNurse Practitioner13Under 11$675
Cheryl G Williams Mount Vernon, MOFamily Practice13Under 11$675
Nancey M Hahn Paoli, PAObstetrics & Gynecology13Under 11$626
Margaret Beaudrot Memphis, TNObstetrics & Gynecology12Under 11$625
William Tsai Upland, CAFamily Practice13Under 11$619
Matthew S Payne Idaho Falls, IDFamily Practice11Under 11$608
Tammy L Eisentrout Canton, OHFamily Practice12Under 11$552
Breann S Farr Canton, ILNurse Practitioner13Under 11$536
Alisha Jackson Peru, ILNurse Practitioner13Under 11$530
Tanya M Williams Salt Lake City, UTFamily Practice12Under 11$500
Jaime Dickerson Miami, FLObstetrics & Gynecology13Under 11$461
Tolulope B Fatokun Somerset, KYObstetrics & Gynecology12Under 11$452
Shelby L Steffen Lincoln, NEFamily Practice13Under 11$448
John S Mays Saint Louis, MOInternal Medicine13Under 11$408
Patrick B Murphy Long Beach, CAEmergency Medicine14Under 11$328
Kathryn Collette Cumberland, MDNurse Practitioner11Under 11$327
Kristy G Chappell Powderly, KYFamily Practice15Under 11$293
Kimberly B Walker Mechanicsville, VAFamily Practice13Under 11$282
Amber C Webb Sheridan, ARNurse Practitioner12Under 11$282
Shannon L Slocum Saint Ignace, MINurse Practitioner19Under 11$278
Louise B Halbleib Custer, SDFamily Practice13Under 11$276
Cathie F Miller Shelton, CTCertified Nurse Midwife14Under 11$273
Leslie A Dudley Pasadena, CAInternal Medicine12Under 11$264

Prescriber data by year

YearPrescribersClaimsPatientsCost
20221,1583,9171,031$210K
20231,0933,373978$172K
20241,1433,3671,044$129K

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Lupin PharmaceuLUPIN.NS logoLUPIN.NS3,369$129K

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
1
RxNorm concept IDs
1543553, 630734, 748797, 748798
Application numbers
ANDA201661

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube